BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 27722599)

  • 1. Glycomic profiling of targeted serum haptoglobin for gastric cancer using nano LC/MS and LC/MS/MS.
    Lee SH; Jeong S; Lee J; Yeo IS; Oh MJ; Kim U; Kim S; Kim SH; Park SY; Kim JH; Park SH; Kim JH; An HJ
    Mol Biosyst; 2016 Nov; 12(12):3611-3621. PubMed ID: 27722599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Designation of fingerprint glycopeptides for targeted glycoproteomic analysis of serum haptoglobin: insights into gastric cancer biomarker discovery.
    Lee J; Hua S; Lee SH; Oh MJ; Yun J; Kim JY; Kim JH; Kim JH; An HJ
    Anal Bioanal Chem; 2018 Feb; 410(6):1617-1629. PubMed ID: 29285644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LC-MS/MS isomeric profiling of permethylated N-glycans derived from serum haptoglobin of hepatocellular carcinoma (HCC) and cirrhotic patients.
    Huang Y; Zhou S; Zhu J; Lubman DM; Mechref Y
    Electrophoresis; 2017 Sep; 38(17):2160-2167. PubMed ID: 28543513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct analysis of aberrant glycosylation on haptoglobin in patients with gastric cancer.
    Kim JH; Lee SH; Choi S; Kim U; Yeo IS; Kim SH; Oh MJ; Moon H; Lee J; Jeong S; Choi MG; Lee JH; Sohn TS; Bae JM; Kim S; Min YW; Lee H; Lee JH; Rhee PL; Kim JJ; Lee SJ; Kim ST; Lee J; Park SH; Park JO; Park YS; Lim HY; Kang WK; An HJ; Kim JH
    Oncotarget; 2017 Feb; 8(7):11094-11104. PubMed ID: 28052004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Site-specific and linkage analyses of fucosylated N-glycans on haptoglobin in sera of patients with various types of cancer: possible implication for the differential diagnosis of cancer.
    Takahashi S; Sugiyama T; Shimomura M; Kamada Y; Fujita K; Nonomura N; Miyoshi E; Nakano M
    Glycoconj J; 2016 Jun; 33(3):471-82. PubMed ID: 26869352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liquid chromatography mass spectrometry-based O-glycomics to evaluate glycosylation alterations in gastric cancer.
    He Y; Xie Q; Wang Y; Liang Y; Xu X; Li Y; Miao J; Chen Z; Li Y
    Proteomics Clin Appl; 2016 Feb; 10(2):206-15. PubMed ID: 26255982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Site-specific analysis of N-glycans on haptoglobin in sera of patients with pancreatic cancer: a novel approach for the development of tumor markers.
    Nakano M; Nakagawa T; Ito T; Kitada T; Hijioka T; Kasahara A; Tajiri M; Wada Y; Taniguchi N; Miyoshi E
    Int J Cancer; 2008 May; 122(10):2301-9. PubMed ID: 18214858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spatially-resolved exploration of the mouse brain glycome by tissue glyco-capture (TGC) and nano-LC/MS.
    Ji IJ; Hua S; Shin DH; Seo N; Hwang JY; Jang IS; Kang MG; Choi JS; An HJ
    Anal Chem; 2015 Mar; 87(5):2869-77. PubMed ID: 25643168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ESI-LC-MS Method for Haptoglobin Fucosylation Analysis in Hepatocellular Carcinoma and Liver Cirrhosis.
    Zhang Y; Zhu J; Yin H; Marrero J; Zhang XX; Lubman DM
    J Proteome Res; 2015 Dec; 14(12):5388-95. PubMed ID: 26503433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycosylation status of haptoglobin in sera of patients with prostate cancer vs. benign prostate disease or normal subjects.
    Fujimura T; Shinohara Y; Tissot B; Pang PC; Kurogochi M; Saito S; Arai Y; Sadilek M; Murayama K; Dell A; Nishimura S; Hakomori SI
    Int J Cancer; 2008 Jan; 122(1):39-49. PubMed ID: 17803183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycosylation of serum haptoglobin as a marker of gastric cancer: an overview for clinicians.
    Jeong S; Oh MJ; Kim U; Lee J; Kim JH; An HJ
    Expert Rev Proteomics; 2020 Feb; 17(2):109-117. PubMed ID: 32149536
    [No Abstract]   [Full Text] [Related]  

  • 12. Exploring serum and immunoglobulin G N-glycome as diagnostic biomarkers for early detection of breast cancer in Ethiopian women.
    Gebrehiwot AG; Melka DS; Kassaye YM; Gemechu T; Lako W; Hinou H; Nishimura SI
    BMC Cancer; 2019 Jun; 19(1):588. PubMed ID: 31208374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Robust Glycoproteomics Platform Reveals a Tetra-Antennary Site-Specific Glycan Capping with Sialyl-Lewis Antigen for Early Detection of Gastric Cancer.
    Liu L; Liu L; Wang Y; Fang Z; Bian Y; Zhang W; Wang Z; Gao X; Zhao C; Tian M; Liu X; Qin H; Guo Z; Liang X; Dong M; Nie Y; Ye M
    Adv Sci (Weinh); 2024 Mar; 11(9):e2306955. PubMed ID: 38084450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LC-MS/MS glycomics of idiopathic rapid eye movement sleep behavior disorder.
    Dong X; Mondello S; Kobeissy F; Talih F; Ferri R; Mechref Y
    Electrophoresis; 2018 Dec; 39(24):3096-3103. PubMed ID: 30168606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast cancer diagnosis and prognosis through quantitative measurements of serum glycan profiles.
    Kyselova Z; Mechref Y; Kang P; Goetz JA; Dobrolecki LE; Sledge GW; Schnaper L; Hickey RJ; Malkas LH; Novotny MV
    Clin Chem; 2008 Jul; 54(7):1166-75. PubMed ID: 18487288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the serum N-linked glycome for the diagnosis of cancer and chronic inflammation.
    Arnold JN; Saldova R; Hamid UM; Rudd PM
    Proteomics; 2008 Aug; 8(16):3284-93. PubMed ID: 18646009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of haptoglobin N-glycome alterations in inflammatory and malignant lung diseases by capillary electrophoresis.
    Váradi C; Mittermayr S; Szekrényes Á; Kádas J; Takacs L; Kurucz I; Guttman A
    Electrophoresis; 2013 Aug; 34(16):2287-94. PubMed ID: 23580236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isomer-specific profiling of N-glycans derived from human serum for potential biomarker discovery in pancreatic cancer.
    Liu Y; Wang C; Wang R; Wu Y; Zhang L; Liu BF; Cheng L; Liu X
    J Proteomics; 2018 Jun; 181():160-169. PubMed ID: 29674015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative LC-MS/MS Glycomic Analysis of Biological Samples Using AminoxyTMT.
    Zhou S; Hu Y; Veillon L; Snovida SI; Rogers JC; Saba J; Mechref Y
    Anal Chem; 2016 Aug; 88(15):7515-22. PubMed ID: 27377957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative liquid chromatography-mass spectrometry-multiple reaction monitoring (LC-MS-MRM) analysis of site-specific glycoforms of haptoglobin in liver disease.
    Sanda M; Pompach P; Brnakova Z; Wu J; Makambi K; Goldman R
    Mol Cell Proteomics; 2013 May; 12(5):1294-305. PubMed ID: 23389048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.